Tufts Medical Center in Boston, Massachusetts is a downtown Boston hospital occupying space between Chinatown and the Boston Theater District.

There are 415 beds in Tufts Medical Center.

During the past decade, Tufts Medical Center conducted 412 clinical trials. In the 10-year time frame, 412 clinical trials started and 286 clinical trials were completed, i.e. on average, 69.4% percent of trials that started reached the finish line to date. In the past 5 years, 183 clinical trials started and 165 clinical trials were completed. i.e. 90.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tufts Medical Center" #1 sponsor was "Tufts Medical Center" with 118 trials, followed by "National Cancer Institute (NCI)" with 44 trials sponsored, "Eastern Cooperative Oncology Group" with 34 trials sponsored, "Pfizer" with 21 trials sponsored and "Gilead Sciences" with 21 trials sponsored. Other sponsors include 611 different institutions and companies that sponsored additional 297 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tufts Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 107 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 26 trials as a collaborator, "Tufts Medical Center" with 26 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 17 trials as a collaborator and "National Center for Research Resources (NCRR)" with 12 trials as a collaborator. Other collaborators include 479 different institutions and companies that were collaborators in the rest 298 trials.

According to Clinical.Site data, the most researched conditions in "Tufts Medical Center" are "Pulmonary Arterial Hypertension" (29 trials), "Heart Failure" (27 trials), "Pulmonary Hypertension" (26 trials), "HIV Infections" (25 trials) and "Breast Cancer" (19 trials). Many other conditions were trialed in "Tufts Medical Center" in a lesser frequency.

Most popular intervention types in "Tufts Medical Center" are "Drug" (544 trials), "Device" (138 trials), "Other" (126 trials), "Biological" (110 trials) and "Procedure" (66 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (136 trials), "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (31 trials), "Paclitaxel" (25 trials) and "Carboplatin" (17 trials). Other intervention names were less common.

The vast majority of trials in "Tufts Medical Center" are 763 trials for "All" genders, 76 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 236 active trials in "Tufts Medical Center". 5 are not yet recruiting, 112 are recruiting, 109 are Active, not recruiting, and 10 are Enrolling by invitation. In total, there were 463 completed trials in Tufts Medical Center, 4 suspended trials, and 112 terminated clinical trials to date.

Out of the total trials that were conducted in Tufts Medical Center, 59 "Phase 1" clinical trials were conducted, 256 "Phase 2" clinical trials and 287 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 34 trials, and there were also 140 trials that are defined as “Not Applicable".

Tufts Medical Center has several departments that took part in Clinical trials: "Tufts-NEMC Cancer Center" - 36 trials, "Floating Hospital for Children at Tufts Medical Center" - 34 trials, "Tufts Medical Center; Ophthalmology" - 11 trials, "Tufts Medical Center, Department of Dermatology" - 9 trials, "Tufts Medical Center, Division of Rheumatology" - 7 trials, "Tufts Medical Center - Center for Wound Healing" - 3 trials, "Pulmonary/Critical Care Division/Tufts New England Medical Center" - 2 trials, "New England Med Ctr / Div of Geo Med & Infect Disease" - 2 trials, "New England Cardiovascular Specialists" - 2 trials